D-0322-2023 Class II Terminated
FDA drug recall D-0322-2023 was initiated by Sentara Infusion Services on Dec 27, 2022 and is designated Class II. Reason for recall: Lack of sterility assurance The recall status is terminated (terminated Feb 20, 2026). Affected quantity: 155 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- Feb 22, 2023
- Initiation Date
- Dec 27, 2022
- Termination Date
- Feb 20, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 155 bags
Product Description
Vancomycin (a) 1.25GM IN NS 250ML, (b) 1.5GM IN NS 300ML, (c) 1000MG IN NS 200ML (d) 2GM IN 400ML NS, (e) 900MG IN NS 180ML, (f) 500 MG NS 100ML, (g) 750 MG NS 150ML, antibiotic, Rx only, use with home pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Reason for Recall
Lack of sterility assurance
Distribution Pattern
Dispensed to Patients Nationwide.
Code Information
Beyond Use Date: December 24-31, 2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0322-2023
- openFDA file date
- Oct 21, 2026
- Loaded by RegDataLab
- Oct 23, 2026